Venu G. Pillarisetty

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 12 papers. Top paper: “Blockade of interleukin 10 potentiates antitumour immune function in human colorectal cancer liver metastases”.

Blockade of interleukin 10 potentiates antitumour immune function in human colorectal cancer liver metastases

Gut(2022)10.1136/gutjnl-2021-325808

N/A

3.3DataRank · unranked

140 citations

Xiuyun Jiang, Prajna Guha, Christopher Lausted, Jason A. Carter, Cynthia L. Hsu +18 more

Modulation of Immune Checkpoints by Chemotherapy in Human Colorectal Liver Metastases

Cell Reports Medicine(2020)10.1016/j.xcrm.2020.100160

N/A

1.1DataRank · unranked

35 citations

Heidi L. Kenerson, Christopher Lausted, Xiaowei Yan, Changting Meng, Kevin M. Sullivan +7 more

Neoantigen-specific CD4+ T cells in human melanoma have diverse differentiation states and correlate with CD8+ T cell, macrophage, and B cell function

Cancer Cell(2022)10.1016/j.ccell.2022.03.006

N/A

0DataRank · unranked

146 citations

Sylvia M. Lee, Carolyn Shasha, Naina Singhi, Julia Szeto, Ata S. Moshiri +17 more

Production of an interleukin-10 blocking antibody by genetically engineered macrophages increases cancer cell death in human gastrointestinal tumor slice cultures

Research Square(2022)10.21203/rs.3.rs-2274380/v1

N/A

0DataRank · unranked

0 citations

Kevin P. Labadie, Shannon Kreuser, Katherine J. Brempelis, Sara K. Daniel, Xiuyun Jiang +6 more

Organotypic Models for Functional Drug Testing of Human Cancers

BME Frontiers(2023)10.34133/bmef.0022

N/A

0DataRank · unranked

22 citations

Lindsay K. Dickerson, Heidi L. Kenerson, Xiuyun Jiang, Venu G. Pillarisetty, Qiang Tian +4 more

Enhanced Complement Expression in the Tumor Microenvironment Following Neoadjuvant Therapy: Implications for Immunomodulation and Survival in Pancreatic Ductal Adenocarcinoma

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.10.26.564099

N/A

0DataRank · unranked

1 citations

Ruoxin Lan, Yongjun Liu, Yongjun Liu, Venu G. Pillarisetty, Danting Li +11 more

Intratumoral T-cell receptor repertoire composition predicts overall survival in patients with pancreatic ductal adenocarcinoma

OncoImmunology(2024)10.1080/2162402x.2024.2320411

N/A

0DataRank · unranked

16 citations

Graham D. Hogg, Leah Conant, Nicholas Borcherding, C. Alston James, Jacqueline L. Mudd +7 more

Reversing immunosuppression in the tumor microenvironment of fibrolamellar carcinoma via PD-1 and IL-10 blockade

Scientific Reports(2024)10.1038/s41598-024-55593-6

N/A

0DataRank · unranked

9 citations

Kevin M. Sullivan, Lindsay K. Dickerson, Renske J.E. van den Bijgaart, Alan F. Utria, Kevin P. Labadie +12 more

Enhanced Complement Expression in the Tumor Microenvironment Following Neoadjuvant Therapy: Implications for Immunomodulation and Survival in Pancreatic Ductal Adenocarcinoma

Research Square(2024)10.21203/rs.3.rs-4104258/v1

N/A

0DataRank · unranked

1 citations

Ruoxin Lan, Yongjun Liu, Venu G. Pillarisetty, Danting Li, Chaohui Zhao +11 more

Genetically engineered macrophages persist in solid tumors and locally deliver therapeutic proteins to activate immune responses

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-001356

N/A

0DataRank · unranked

82 citations

Courtney M Cowan, Shannon Kreuser, Kevin P. Labadie, Brooke M Prieskorn, Nicole A. P. Lieberman +19 more

Complement activation in tumor microenvironment after neoadjuvant therapy and its impact on pancreatic cancer outcomes

npj Precision Oncology(2025)10.1038/s41698-025-00848-2

N/A

0DataRank · unranked

11 citations

Ruoxin Lan, Yongjun Liu, Venu G. Pillarisetty, Danting Li, Chaohui Zhao +11 more

Homologous recombination deficiency (HRD) by BROCA-HR and survival outcomes after surgery for patients (pts) with pancreatic adenocarcinoma (PC): A single institution experience.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.4_suppl.732

N/A

0DataRank · unranked

1 citations

David B. Zhen, Marc R. Radke, Kelsey K. Baker, Andrew L. Coveler, Kit Man Wong +5 more